日清食品公告，公司的控股股东Nissin Foods Holdings Co.,Ltd.(日清日本)于截至2025年12月31日止九个 月期间于中国业务分部的收入为535.44亿日圆，核心经营溢利为57.10亿日圆，同比增长6.5%；及经营 溢利为56.72亿日圆，同比增长99.8%。撇除汇率因素后，收入为549.48亿日圆，同比增长2.7%；及核心 经营溢利为58.59亿日圆，同比增长9.3%。 香港联交所最新资料显示，2月26日，日清食品(01475)股东将股票存入大和资本市场香港，存仓市值 55.23亿港元，占比70%。 ...

日清食品公告，公司的控股股东Nissin Foods Holdings Co., Ltd.(日清日本)于截至2025年12月31日止九个 月期间于中国业务分部的收入为535.44亿日圆，核心经营溢利为57.10亿日圆，同比增长6.5%；及经营 溢利为56.72亿日圆，同比增长99.8%。撇除汇率因素后，收入为549.48亿日圆，同比增长2.7%；及核心 经营溢利为58.59亿日圆，同比增长9.3%。 智通财经APP获悉，香港联交所最新资料显示，2月26日，日清食品(01475)股东将股票存入大和资本市 场香港，存仓市值55.23亿港元，占比70%。 ...

Investment Rating - The report maintains a positive outlook on Nissin Foods, indicating strong quarterly performance and consistent sales guidance for the fiscal year 2026 [4][5]. Core Insights - Nissin Foods reported robust quarterly results with sales of 213 billion JPY and operating profit of 21.6 billion JPY for Q3 FY2026, exceeding market expectations [4]. - The company’s sales in the U.S. market grew by 5%, marking the first positive growth in five quarters, which contributed to the overall positive market reaction [4]. - Nissin's overseas sales increased by 5.3% to 75.3 billion JPY, with the Americas showing an 8.4% growth, while the Chinese market experienced a decline of 2.3% [5]. Summary by Sections Financial Performance - For Q3 FY2026, Nissin Foods achieved sales of 213.3 billion JPY (up 4.5% year-on-year) and operating profit of 21.6 billion JPY (up 14.6% year-on-year), aligning with market expectations [4]. - The company maintained its full-year guidance, projecting sales of 792 billion JPY (up 2.0% year-on-year) and core operating profit of 68.5 billion JPY (down 18.0% year-on-year) [5]. Business Segments - Nissin's overseas business, including the Americas, China, Asia, and EMEA, reported a sales increase of 5.3% to 75.3 billion JPY, with a notable operating profit margin of 12.8% [5]. - The U.S. market's sales growth was driven by a 3.8% same-store sales increase, while the Brazilian market also saw a 5% increase [5]. Market Position - As of February 3, 2026, Nissin Foods' stock price was 3,253 JPY, with a market capitalization of 5.57 billion USD [10]. - The company has a strong asset base of 812 billion JPY and is focused on maintaining a significant share of its sales from domestic operations [8].

Major Events - InnoCare Pharma (09926) granted exclusive commercialization rights of Yixineng® to Jichuan Pharmaceutical [1] - Ying Si Intelligent (03696) received a milestone payment of HKD 39 million from Menarini, with the MEN2501 project completing its first patient dosing [1] - Xiansheng Pharmaceutical (02096) received a recent milestone payment related to the overseas licensing option agreement for SIM0500 with AbbVie [1] - Innovent Biologics (02577) completed significant design integration for related products on Google's AI hardware platform and signed a compliant supply agreement [1] - Federal Pharmaceutical (03933) obtained implied approval for clinical trials of UBT251 injection for OSA indications [1] - Kanghong Pharmaceutical (00867) received clinical trial approval for the innovative drug CMS-D017 capsule for complement-mediated kidney disease indications [1] - First Capital Holdings (00697) announced the successful IPO and listing of Shimon Holdings on the Shenzhen Stock Exchange [1] Operating Performance - Country Garden (02007) achieved a contract sales amount of approximately CNY 2.21 billion attributable to shareholders by January 2026 [1] - Nissin Foods (01475) reported an operating profit of JPY 5.672 billion from its China business segment for the first three quarters, representing a year-on-year increase of 99.8% [1] - Natural Beauty (00157) issued a profit warning, expecting an annual net profit of approximately HKD 8 million to HKD 10 million, marking a turnaround from losses [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2026年1月31日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | 公司名稱: | 日清食品有限公司 | | | 呈交日期: | 2026年2月3日 | | | I. 法定/註冊股本變動 | 不適用 | | FF301 第 1 頁 共 10 頁 v 1.2.0 FF301 II. 已發行股份及/或庫存股份變動及足夠公眾持股量的確認 1. 股份分類 普通股 股份類別 不適用 於香港聯交所上市 (註1) 是 證券代號 (如上市) 01475 說明 已發行股份（不包括庫存股份）數目 庫存股份數目 已發行股份總數 上月底結存 1,043,691,480 0 1,043,691,480 增加 / 減少 (-) 0 0 本月底結存 1,043,691,480 0 1,043,691,480 足夠公眾持股量的確認(註4) | 根據《主板上市規則》第13.32D(1)條或第19A.28D(1)條 / 《GEM上市規則》第17.37D(1)條或第25.21D(1 ...

日清食品(01475)发布公告，公司的控股股东Nissin Foods Holdings Co., Ltd.(日清日本)于截至2025年12月 31日止九个月期间于中国业务分部的收入为535.44亿日圆，核心经营溢利为57.10亿日圆，同比增长 6.5%;及经营溢利为56.72亿日圆，同比增长99.8%。撇除汇率因素后，收入为549.48亿日圆，同比增长 2.7%;及核心经营溢利为58.59亿日圆，同比增长9.3%。 ...

香 港 交 易 及 結 算 所 有 限 公 司 及 香 港 聯 合 交 易 所 有 限 公 司 對 本 公 告 之 內 容 概 不 負 責， 對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全 部 或 任 何 部 份 內 容 而 產 生 或 因 倚 賴 該 等 內 容 而 引 致 之 任 何 損 失 承 擔 任 何 責 任。 Nissin Foods Company Limited 日 清 食 品 有 限 公 司 NISSIN FOODS HOLDINGS CO., LTD. 截 至2025年12月31日止九個月之 未經審核財務業績 本 公 告 乃 日 清 食 品 有 限 公 司（「本 公 司」，連 同 其 附 屬 公 司 統 稱「本 集 團」）根 據 香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則（「上 市 規 則」）第13.09(2)條及香港法例第571章證券及 期貨條例第XIVA部 之 內 幕 消 息 條 文 作 出。 本公司的控股股東Nissin Foods Holdings Co., Ltd.（「日清日本」）於日 ...

香港联交所最新资料显示，1月23日，董事长安藤清隆增持日清食品(01475)3万股，每股均价7.1港元， 总金额为21.3万港元。增持后最新持股数目为2183.6万股，最新持股比例2.09%。 ...

智通财经APP获悉，香港联交所最新资料显示，1月23日，董事长安藤清隆增持日清食品(01475)3万股， 每股均价7.1港元，总金额为21.3万港元。增持后最新持股数目为2183.6万股，最新持股比例2.09%。 ...

Group 1 - The core point of the news is that Nissin Foods (01475.HK) CEO Ando Kiyotaka increased his shareholding by acquiring 234,000 shares at an average price of HKD 7.0645 to 7.10, totaling approximately HKD 1.6542 million [1] - Following the purchase, Ando Kiyotaka's total shareholding reached 21.836 million shares, with his ownership percentage rising from 2.07% to 2.09% [1]